Red Light Therapy for Beard Growth

Patchy or thin beard growth is a common frustration. Genetics play the dominant role — the density, distribution, and thickness of facial hair follicles are largely determined by androgen sensitivity and hereditary factors. But for men whose follicles are present but underperforming, the question of whether red light therapy can push those follicles toward thicker, more consistent growth is worth examining.

The honest answer: there are no published clinical trials specifically studying red light therapy for beard growth. Zero. What we have is a strong body of evidence for photobiomodulation and scalp hair growth, a well-understood biological mechanism, and reasonable grounds for extrapolation. This page lays out that evidence, explains the biology, and sets realistic expectations.

How beard hair grows

Beard hair is androgen-dependent terminal hair — its growth is driven primarily by dihydrotestosterone (DHT), a potent androgen converted from testosterone by the enzyme 5-alpha reductase. This is the opposite dynamic to scalp hair, where DHT causes miniaturisation and loss in androgenetic alopecia.

The beard growth timeline follows a familiar pattern:

Puberty to early twenties: Vellus hairs (fine, light, barely visible) on the face begin to transform into terminal hairs (thick, pigmented, coarse) under the influence of rising androgen levels. This process starts at the upper lip and chin, then spreads to the cheeks, jawline, and neck.

Twenties to thirties: Beard density continues to increase. Many men do not reach their full beard potential until their late twenties or even early thirties.

The growth cycle: Like all hair, beard follicles cycle through anagen (growth), catagen (transition), and telogen (resting) phases. The anagen phase for beard hair is approximately two to six months — longer than eyebrow hair but generally shorter than scalp hair. This is why beards reach a natural maximum length.

The critical point: if a hair follicle lacks androgen receptors or has insufficient DHT sensitivity, no amount of external stimulation will convert it to terminal hair production. Red light therapy cannot change your genetic blueprint for beard density.

The evidence from scalp hair growth

The case for red light therapy and beard growth rests almost entirely on extrapolation from scalp studies. Here is what those studies demonstrate:

Key clinical trials

Lanzafame et al. (2014) — A double-blind, sham-controlled RCT of 655nm red light for androgenetic alopecia. After 16 weeks, the active group showed a 39 per cent increase in hair count compared with sham (Lasers in Surgery and Medicine, 46(8), 601-607).

Kim et al. (2013) — A randomised, double-blind trial using a 655nm helmet device. After 24 weeks, the treatment group showed significant increases in hair density and thickness compared with the sham group (Lasers in Medical Science, 28(6), 1471-1479).

Jimenez et al. (2014) — A large multicentre RCT (128 subjects) using a 655nm laser comb. Both men and women showed significant increases in hair density after 26 weeks (American Journal of Clinical Dermatology, 15(2), 115-127).

The biological mechanisms

These trials demonstrate effects mediated by several well-characterised pathways:

Mitochondrial stimulation. Red light at 630 to 670nm is absorbed by cytochrome c oxidase in the mitochondria of dermal papilla cells — the master regulators of hair follicle cycling. This increases ATP production and enhances cell proliferation. Kim et al. (2017) confirmed that 660nm light at 3 J/cm² significantly increased dermal papilla cell proliferation and upregulated hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) in vitro (Lasers in Medical Science, 32(9), 2085-2093).

Telogen to anagen shift. Red light therapy appears to prompt resting follicles to re-enter the active growth phase. This means more hairs growing simultaneously, producing visibly thicker coverage.

Increased blood flow. Photobiomodulation promotes nitric oxide release from endothelial cells, causing local vasodilation. Improved blood supply to the dermal papilla supports follicle function and nutrient delivery.

Anti-inflammatory effects. Chronic perifollicular inflammation can impair hair growth. Red light therapy reduces TNF-alpha, IL-6, and other pro-inflammatory mediators (Hamblin, 2017, AIMS Biophysics, 4(3), 337-361).

Can these mechanisms apply to beard follicles?

The biology is the same. Beard follicle dermal papilla cells contain cytochrome c oxidase. They cycle through the same growth phases. They depend on blood supply and are affected by inflammation. There is no reason to believe the cellular response to red light would differ between scalp and facial follicles.

However, there are important distinctions:

Androgen dependence changes the equation. Scalp hair loss in androgenetic alopecia involves DHT-mediated follicle miniaturisation. Red light therapy for scalp hair works partly by counteracting this miniaturisation. Beard follicles have a different relationship with DHT — they depend on it for growth. Red light therapy does not increase DHT levels. If your beard is thin because your follicles have low androgen receptor expression, red light cannot fix that.

The problem might be vellus follicles, not dormant ones. On the scalp, red light therapy can help miniaturised follicles (which were once terminal) return to producing thicker hairs. On the face, bare patches may represent areas where follicles have never transitioned from vellus to terminal. Red light therapy has no established mechanism for triggering this transition — that process is hormonally driven.

What red light therapy might help: If you have visible (but thin) beard hairs, red light therapy could plausibly increase their thickness and growth rate by improving follicle health. If you have patchy areas where hairs grow inconsistently, promoting more follicles into anagen simultaneously could improve perceived density.

What red light therapy probably cannot help: If areas of your face have never grown any visible hair, the follicles likely lack the androgen sensitivity to produce terminal hairs. Red light therapy is unlikely to change this.

Suggested protocol

No beard-specific protocols exist in the literature. The following is adapted from successful scalp hair growth studies:

• Wavelength: 630 to 660nm (red)
• Power density: 10 to 40 mW/cm²
• Dose per session: 3 to 6 J/cm² (approximately 3 to 5 minutes with a handheld device at close range)
• Frequency: Every other day (3 to 4 sessions per week)
• Duration: Minimum 16 to 24 weeks before assessing results
• Application: Hold the device 2 to 5cm from the face, treating the beard area systematically

Practical considerations

Device choice: A handheld wand or small panel is most practical for treating the face. Full panels work but waste most of their output on non-target areas. LED face masks deliver red light to the face but are designed for skin treatment rather than hair growth, and their irradiance may be too low for follicle stimulation.

Combine with derma rolling (optional). Some anecdotal protocols combine red light therapy with microneedling (0.5mm derma roller) on the beard area. Microneedling creates controlled micro-injuries that trigger wound healing signalling cascades, including release of growth factors. A small study by Dhurat et al. (2013) showed microneedling combined with minoxidil outperformed minoxidil alone for scalp hair growth (International Journal of Trichology, 5(1), 6-11). No studies have examined the microneedling + red light combination for beard growth specifically.

Consider minoxidil. Topical minoxidil (5%) has growing anecdotal support for beard growth, though the published evidence is limited to a Thai study by Suchonwanit et al. (2019) showing improved facial hair density over 16 weeks (Journal of Dermatology, 46(12), 1181-1186). If you are serious about maximising beard growth, combining minoxidil with red light therapy addresses different mechanisms (minoxidil primarily works as a potassium channel opener and vasodilator) and may produce synergistic effects. Discuss with your doctor first.

Realistic expectations

Likely outcomes with consistent use:

• Slightly thicker individual beard hairs in areas where hair already grows
• More consistent coverage as a greater proportion of follicles enter anagen simultaneously
• Healthier skin beneath the beard (reduced inflammation, improved circulation)

Unlikely outcomes:

• Growth of new terminal hairs in completely bare areas
• Dramatic transformation of a patchy beard into a full one
• Rapid results — hair follicles cycle slowly, and meaningful changes require months

Timeline: Commit to a minimum of four to six months of consistent treatment before judging results. Take photographs under consistent lighting at monthly intervals. Without photos, gradual changes are difficult to perceive.

The bottom line

Red light therapy for beard growth is biologically plausible but clinically unproven for this specific application. The mechanisms that promote scalp hair growth — mitochondrial stimulation, increased blood flow, anti-inflammatory effects, telogen-to-anagen conversion — apply equally to facial follicles at the cellular level.

The most important caveat is that red light therapy cannot overcome genetic limitations. If your beard patchiness is due to follicles that lack androgen sensitivity, no external therapy will convert them to terminal hair producers. But if your follicles are present, capable of producing terminal hairs, and simply underperforming, red light therapy is a low-risk intervention that may help.

The cost is minimal if you already own a suitable device. The risk is negligible. The time commitment is modest. Set your expectations accordingly, give it at least four months, and let the results — or lack thereof — guide your decision.